Other musculoskeletal disorders in China, 1990-2021, and projections to 2050: findings from the Global Burden of Disease Study 2021.

IF 2.9 3区 医学 Q2 RHEUMATOLOGY
Clinical Rheumatology Pub Date : 2025-06-01 Epub Date: 2025-04-30 DOI:10.1007/s10067-025-07459-z
Suying Liu, Yingying Chen, Liuting Zeng, Siyu Cao, Juan Meng, Fengchun Zhang
{"title":"Other musculoskeletal disorders in China, 1990-2021, and projections to 2050: findings from the Global Burden of Disease Study 2021.","authors":"Suying Liu, Yingying Chen, Liuting Zeng, Siyu Cao, Juan Meng, Fengchun Zhang","doi":"10.1007/s10067-025-07459-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Other musculoskeletal disorders showed a growing burden globally, but data specific to China remain sparse. This study aims to analyze the burden of other musculoskeletal disorders in China from 1990 to 2021 using data from the Global Burden of Disease (GBD) 2021.</p><p><strong>Methods: </strong>Decomposition analysis, Bayesian Age-Period-Cohort, and Age-Period-Cohort models were utilized to investigate the key influencing factors and project future burden.</p><p><strong>Results: </strong>In China, the prevalence of other musculoskeletal disorders was 85.0 (72.4-99.4) million in 2021, with a 20% increase from 1990. The number of Disability-Adjusted Life Years (DALYs) was 7.6 (5.2-10.6) million in 2021, indicating a 18.1% rise. Although age-standardized mortality rate remained stable, deaths number increased from 5,279.4 (4,289.9-6,724.3) to 9,166.9 (7,000.8-11,693.4). Females consistently showed higher rates than males, while China remained below the global average in prevalence, DALYs, and mortality. Population growth was the predominant contributor to the burden's increase in China, showing a different pattern from other BRICS countries. Prevalence is projected to triple by 2050, while DALYs and mortality may decline. For Age-Period-Cohort analysis of mortality, net drift was below zero. Age effects exhibited a significant increase after age group 70-75. Period effects played a negative role after 2004-2005. Cohort effects revealed a notable decrease among more recent generation.</p><p><strong>Conclusions: </strong>The burden of other musculoskeletal disorders in China is increasing with sex, age, and regional differences. Future growth in prevalence is predicted for this category of disorders, highlighting the need for effective public health policies and tailored interventions. Key Points • The burden of other musculoskeletal disorders in China is substantial and has been growing from 1990 to 2021, with significant sex, age, and regional differences. • Population growth is the predominant contributor to the increased burden of other musculoskeletal disorders in China, showing a distinct pattern compared to other BRICS countries.</p>","PeriodicalId":10482,"journal":{"name":"Clinical Rheumatology","volume":" ","pages":"2119-2130"},"PeriodicalIF":2.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10067-025-07459-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Other musculoskeletal disorders showed a growing burden globally, but data specific to China remain sparse. This study aims to analyze the burden of other musculoskeletal disorders in China from 1990 to 2021 using data from the Global Burden of Disease (GBD) 2021.

Methods: Decomposition analysis, Bayesian Age-Period-Cohort, and Age-Period-Cohort models were utilized to investigate the key influencing factors and project future burden.

Results: In China, the prevalence of other musculoskeletal disorders was 85.0 (72.4-99.4) million in 2021, with a 20% increase from 1990. The number of Disability-Adjusted Life Years (DALYs) was 7.6 (5.2-10.6) million in 2021, indicating a 18.1% rise. Although age-standardized mortality rate remained stable, deaths number increased from 5,279.4 (4,289.9-6,724.3) to 9,166.9 (7,000.8-11,693.4). Females consistently showed higher rates than males, while China remained below the global average in prevalence, DALYs, and mortality. Population growth was the predominant contributor to the burden's increase in China, showing a different pattern from other BRICS countries. Prevalence is projected to triple by 2050, while DALYs and mortality may decline. For Age-Period-Cohort analysis of mortality, net drift was below zero. Age effects exhibited a significant increase after age group 70-75. Period effects played a negative role after 2004-2005. Cohort effects revealed a notable decrease among more recent generation.

Conclusions: The burden of other musculoskeletal disorders in China is increasing with sex, age, and regional differences. Future growth in prevalence is predicted for this category of disorders, highlighting the need for effective public health policies and tailored interventions. Key Points • The burden of other musculoskeletal disorders in China is substantial and has been growing from 1990 to 2021, with significant sex, age, and regional differences. • Population growth is the predominant contributor to the increased burden of other musculoskeletal disorders in China, showing a distinct pattern compared to other BRICS countries.

中国其他肌肉骨骼疾病,1990-2021年,以及到2050年的预测:来自2021年全球疾病负担研究的结果
其他肌肉骨骼疾病在全球范围内显示出日益增长的负担,但针对中国的数据仍然很少。本研究旨在利用全球疾病负担(GBD) 2021的数据,分析1990年至2021年中国其他肌肉骨骼疾病的负担。方法:采用分解分析、贝叶斯年龄-时期-队列模型和年龄-时期-队列模型,探讨关键影响因素和项目未来负担。结果:2021年中国其他肌肉骨骼疾病患病率为85.0万(7240 - 9940万),较1990年增长20%。2021年,残疾调整生命年(DALYs)的数量为760万(520 - 1060万),增长18.1%。虽然年龄标准化死亡率保持稳定,但死亡人数从5,279.4(4,289.9-6,724.3)增加到9,166.9(7,0000.8 -11,693.4)。女性的发病率始终高于男性,而中国的患病率、伤残调整年和死亡率仍低于全球平均水平。人口增长是中国负担增加的主要原因,与其他金砖国家表现出不同的模式。预计到2050年患病率将增加两倍,而残疾调整生命年和死亡率可能下降。对于死亡率的年龄-时期-队列分析,净漂移低于零。年龄效应在70-75岁年龄组后显著增加。时期效应在2004-2005年之后呈现负向作用。群体效应显示,在较近的一代中,这一比例显著下降。结论:中国其他肌肉骨骼疾病的负担随性别、年龄和地区差异而增加。预计这类疾病的流行率今后还会增加,这突出表明需要制定有效的公共卫生政策和有针对性的干预措施。•中国其他肌肉骨骼疾病的负担很大,从1990年到2021年一直在增长,存在显著的性别、年龄和地区差异。•人口增长是中国其他肌肉骨骼疾病负担增加的主要原因,与其他金砖国家相比,表现出独特的模式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Rheumatology
Clinical Rheumatology 医学-风湿病学
CiteScore
6.90
自引率
2.90%
发文量
441
审稿时长
3 months
期刊介绍: Clinical Rheumatology is an international English-language journal devoted to publishing original clinical investigation and research in the general field of rheumatology with accent on clinical aspects at postgraduate level. The journal succeeds Acta Rheumatologica Belgica, originally founded in 1945 as the official journal of the Belgian Rheumatology Society. Clinical Rheumatology aims to cover all modern trends in clinical and experimental research as well as the management and evaluation of diagnostic and treatment procedures connected with the inflammatory, immunologic, metabolic, genetic and degenerative soft and hard connective tissue diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信